Skip to main content

Table 3 Univariate analysis of predictors for overall survival. (n = 38)

From: Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Variables Overall Survival Median p-Value
Age
  ≤ 50 16.7 0.478
 >50 13.8
Gender
 Male 12.1 0.120
 Female 17.5
Treatment
 Conversion therapy 21.1 0.002
 Palliative chemotherapy 10.8
Tumor location
 Upper 11.3 0.343
 Middle and lower 15.7
Differentiation
 Poorly 11.6 0.087
 Moderately and well 18.1
Ascites
 Positive 15.3 0.774
 Negative 14.5
Initial DSL
 PCI<10 16.6 0.391
 PCI ≥ 10 13.2
Second DSL
 PCI<6 20.1 0.006
 PCI ≥ 6 11.3
Serum CEA (ng/ml)
 Normal 15.6 0.373
 >5 12.0
Serum CA19–9 (U/ml)
 Normal 15.9 0.359
 >39 12.1
Serum CA125 (U/ml)
 Normal 10.4 0.076
 >35 17.6
  1. DSL diagnostic staging laparoscopy, PCI peritoneal carcinomatosis index
  2. CEA carcinoembryonic antigen
\